Our Co-Founder and CEO, Tim Guilliams, will be attending “Accelerating Bio-Innovation 2022” – a two-day exploration of some of the key debates facing innovators of new biopharmaceuticals, from both the science and funding perspectives. This unique, interactive and multidisciplinary summit will examine the successes and challenges in drug development including translation of cancer drugs, CAR-T therapies and PROTACs, business innovation in academia, pharma and investments and the future of drug discovery, including the role of artificial intelligence.

We’re looking forward to what’s set to be an insightful session. Will we see you there? If you aren’t attending but would like to learn more about our work, please contact us for more information.